Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Phillip H AbboshLiang Cheng

Abstract

Small-cell carcinoma of the urinary bladder (SCBC) is a rare tumor, which shows a common clonal origin with urothelial carcinoma. It bears a high metastatic potential, even when discovered in a localized state. Identifying the molecular underpinnings of this disease may elucidate useful clinical information regarding prevention, diagnosis, prognosis, treatment, and surveillance. As DNA methylation is widely recognized as having a pivotal role in the process of carcinogenesis, we analyzed the DNA methylation status of four frequently hypermethylated tumor suppressors in small-cell and transitional-cell carcinoma (TCC) arising concomitantly in 13 patients. Fourteen cases of pure TCC were also included in the analysis. We identified frequent methylation of RASSF1 and MGMT and infrequent methylation of MLH1 and DAPK1 in cases of concomitant TCC and SCBC. Similar rates of methylation were found in pure and concomitant histopathologies, with the exception of MGMT, which was much less frequently methylated in pure TCC. These findings suggest that SCBC and TCC have common origins, establish DNA methylation of some tumor suppressors as frequent occurrences in both histopathologies, and suggest that MGMT methylation may be an SCBC-specif...Continue Reading

References

Jan 1, 1995·Progress in Nucleic Acid Research and Molecular Biology·A E PeggR C Moschel
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Apr 13, 1999·The American Journal of Surgical Pathology·L ChengD G Bostwick
Mar 29, 2000·Nucleic Acids Research·C A EadsP W Laird
Jul 26, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J BellmuntJ Baselga
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BellmuntJ Baselga
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
May 3, 2001·Journal of the National Cancer Institute·D G BurbeeJ D Minna
Apr 11, 2002·Virchows Archiv : an International Journal of Pathology·Antonio Lopez-BeltranCatherine Mazerolles
May 30, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshiyuki MatsuiHideo Takeuchi
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Michael W Y ChanKa Fai To
Apr 3, 2003·Nature Reviews. Cancer·Peter W Laird
Nov 7, 2003·Oncogene·Limin LiuGerd P Pfeifer
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
Jan 27, 2004·Nature Cell Biology·Min Sup SongDae-Sik Lim
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Essel DulaimiPaul Cairns
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria F PazManel Esteller
Dec 1, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin G FriedrichGangning Liang
Dec 21, 2004·Current Opinion in Oncology·Manel Esteller
Sep 2, 2005·Molecular and Cellular Biology·L van der WeydenA Bradley
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy D JonesLiang Cheng
Apr 28, 2006·The Journal of Pathology·D DhawanJ W F Catto
Jul 20, 2006·Journal of the National Cancer Institute·Mohammad Obaidul HoqueDavid Sidransky
Feb 27, 2007·Cell·Bing LiJerry L Workman

❮ Previous
Next ❯

Citations

Jan 5, 2011·Pathology Oncology Research : POR·Ma Jesús Fernández-AceñeroCamino Medina
Jan 26, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marta Sánchez-Carbayo
Jun 6, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mahul B Amin
Sep 6, 2011·Genetics·Yan LongJinling Meng
Dec 1, 2011·Epigenomics·Ewa DudziecJames W F Catto
Dec 8, 2015·Environmental and Molecular Mutagenesis·Huiqi LiMaria Albin
Jan 21, 2016·Case Reports in Urology·Ahmet ÇamtosunNusret Akpolat
Oct 15, 2010·Cancer·Filipe Ivan DanielFernanda Gonçalves Salum
May 18, 2013·European Journal of Haematology·Antonella PoloniPietro Leoni
Jul 16, 2015·Lipids in Health and Disease·Yi-Yang LiLi-Mei Fan
Apr 13, 2012·Applied Immunohistochemistry & Molecular Morphology : AIMM·Liang ChengRodolfo Montironi
Nov 7, 2018·The Science of the Total Environment·Emelie Rietz LiljedahlKarin Broberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.